CARDIAC INSIGHT, INC.

Profile

Company Names

CARDIAC INSIGHT, INC.

Addresses

2375 130TH AVE NE STE 101, BELLEVUE, WA 98005-1758

2375 130TH AVENUE NE, SUITE 101, BELLEVUE, WA 98005

3230 CARILLON POINT, KIRKLAND, WA 98033

2815 EASTLAKE AVE. E., SUITE 300, SEATTLE, WA 98102

2815 EASTLAKE AVENUE E., SUITE 300, SEATTLE, WA 98102

2815 EASTLAKE AVENUE E., SUITE 300, SUITE 300, SEATTLE, WA 98102

2002 156TH AVENUE NE, SUITE 150, BELLEVUE, WA 98007

3857 50TH AVE NE, SEATTLE, WA 98105

Phone Numbers

(206) 596-2060
(206) 442-3098
(425) 891-7347

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

WASHINGTON

Total Amount Raised:

$38,113,618.00

Number of Funding Rounds:

13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2022-03-17 
$11,600,000.00 
$12,100,000.00 
$500,000.00 
Debt 
12
2019-07-30 
$4,745,813.00 
$11,759,999.00 
$7,014,186.00 
Equity 
11
2017-05-05 
$2,836,491.00 
$10,000,000.00 
$7,163,509.00 
Equity 
10
2016-11-22 
$1,000,000.00 
$2,400,000.00 
$1,400,000.00 
Equity 
9
2016-04-13 
$2,505,524.00 
$5,000,000.00 
$2,494,476.00 
Debt 
8
2015-09-08 
$3,500,000.00 
$3,500,000.00 
$0.00 
 
7
2014-06-26 
$7,071,452.00 
$9,075,000.00 
$2,003,548.00 
Equity 
6
2014-01-14 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
5
2013-08-06 
$1,354,089.00 
$2,030,104.00 
$676,015.00 
Equity 
4
2012-09-11 
$284,811.00 
$500,000.00 
$215,189.00 
Debt 
3
2011-11-14 
$699,962.00 
$700,000.00 
$38.00 
Equity 
2
2011-09-26 
$315,476.00 
$500,500.00 
$185,024.00 
Debt 
1
2010-12-30 
$200,000.00 
$200,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TOM 
 
CLEMENT 
DIRECTOR, EXECUTIVE OFFICER
KIRBY 
 
CRAMER 
DIRECTOR
KIRBY 
CRAMER 
DIRECTOR
ROBERT 
 
DEGAVRE 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
DEGAVRE 
DIRECTOR
ANN 
 
DEMAREE 
EXECUTIVE OFFICER
LEX 
 
GAMBLE 
DIRECTOR
DAVID 
 
HADLEY 
EXECUTIVE OFFICER
BRAD 
 
HARLOW 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
HAUSER 
DIRECTOR
ROBERT 
HAUSER 
DIRECTOR
HYOUNG MIN 
 
KIM 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
 
LINKER 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
LINKER 
EXECUTIVE OFFICER, DIRECTOR
RICHARD 
MARTIN 
DIRECTOR
KURT 
 
NOLTENSMEYER 
EXECUTIVE OFFICER
BOB 
 
ODELL 
EXECUTIVE OFFICER
ROBERT 
 
ODELL 
EXECUTIVE OFFICER
HEMANTH 
 
REDDY 
DIRECTOR
MICHAEL 
 
SCHUH 
EXECUTIVE OFFICER
MIKE 
 
SCHUH 
EXECUTIVE OFFICER
STACY 
 
SPROUSE 
EXECUTIVE OFFICER
DANIEL 
 
TYLUTKI 
EXECUTIVE OFFICER
BILL 
 
WILLIS 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2022-03-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-04-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2015-09-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-01-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-09-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-09-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#